Ftse Mib
37.055,70
-0,18%
DAX
21.787,00
-0,58%
S&P 500
6.025,99
-0,95%
NASDAQ
19.523,40
-1,36%
Bitcoin
96.697,31
0,16%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Phio Pharmaceuticals Corporation (PHIO) Phio Pharmaceuticals Corporation (PHIO) Notizie

Phio Pharmaceuticals Corporation

PHIO
1,9001
-0,1299 (-6,40%)
08 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/2/202522:09EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
29/1/202522:02EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/1/202522:39EDGAR2Form S-1 - General form for registration of securities under..
17/1/202522:44EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
17/1/202522:05EDGAR2Form 8-K - Current report
17/1/202514:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/1/202522:05EDGAR2Form 8-K - Current report
15/1/202514:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/1/202523:18EDGAR2Form 8-K - Current report
14/1/202519:34EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/1/202516:55EDGAR2Form 8-K - Current report
27/12/202423:05EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
26/12/202422:05EDGAR2Form 8-K - Current report
26/12/202420:19EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
23/12/202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/12/202422:05EDGAR2Form 8-K - Current report
20/12/202414:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/12/202414:38EDGAR2Form 8-K - Current report
14/11/202422:49EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202422:47EDGAR2Form 8-K - Current report
13/11/202417:20EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202416:21EDGAR2Form 8-K - Current report
13/9/202421:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202420:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202423:00EDGAR2Form 8-K - Current report
14/8/202422:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202414:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/8/202414:00EDGAR2Form 8-K - Current report
26/7/202422:30EDGAR2Form S-1 - General form for registration of securities under..
24/7/202422:30EDGAR2Form 8-K - Current report
28/5/202423:00EDGAR2Form 8-K - Current report
20/5/202423:03EDGAR2Form S-3 - Registration statement under Securities Act of..
20/5/202422:59EDGAR2Form RW - Registration Withdrawal Request
17/5/202422:45EDGAR2Form S-3 - Registration statement under Securities Act of..
17/5/202415:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/5/202415:00GLOBEPhio Pharmaceuticals Secures New Investor
17/5/202415:00EDGAR2Form 8-K - Current report
16/5/202414:00GLOBEPhio Pharmaceuticals Presents This Week at the Society for..
15/5/202419:00GLOBEPhio Pharmaceuticals Announces Completion of Dosing in First..
09/5/202423:25GLOBEPhio Pharmaceuticals Reports Q1 2024 Results and Provides..
09/5/202423:23EDGAR2Form 8-K - Current report
09/5/202423:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202423:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/5/202423:02EDGAR2Form DEF 14A - Other definitive proxy statements
30/4/202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
22/4/202419:10GLOBEIntratumoral Injection of Phio’s PH-762 significantly..
16/4/202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentations at the..
11/4/202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
Apertura: 2,03 Min: 1,88 Max: 2,04
Chiusura: 2,03

La tua Cronologia

NASDAQ
PHIO
Phio Pharmaceuticals
AMEX
ZVOL
Volatility Premium Plus ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci